Outlook Therapeutics Inc.

01/12/2021 | Press release | Distributed by Public on 01/12/2021 07:10

Leading Ophthalmology Organization Launches Podcast Video with Firas Rahhal, MD, to Explore the Genesis and Promise of Outlook Therapeutics’ ONS-5010/LYTENAVA™ (bevacizumab-vikg)